APA (7th ed.) Citation

S, B., MG, A., R, V., A, S., D, S., GC, K., . . . CC, M. (2021). N-arachidonoyl dopamine inhibits epithelial-mesenchymal transition of breast cancer cells through ERK signaling and decreasing the cellular cholesterol. Journal of biochemical and molecular toxicology, 35(4), e22693. https://doi.org/10.1002/jbt.22693

Chicago Style (17th ed.) Citation

S, Bandyopadhayaya, Akimov MG, Verma R, Sharma A, Sharma D, Kundu GC, Gretskaya NM, Bezuglov VV, and Mandal CC. "N-arachidonoyl Dopamine Inhibits Epithelial-mesenchymal Transition of Breast Cancer Cells Through ERK Signaling and Decreasing the Cellular Cholesterol." Journal of Biochemical and Molecular Toxicology 35, no. 4 (2021): e22693. https://doi.org/10.1002/jbt.22693.

MLA (9th ed.) Citation

S, Bandyopadhayaya, et al. "N-arachidonoyl Dopamine Inhibits Epithelial-mesenchymal Transition of Breast Cancer Cells Through ERK Signaling and Decreasing the Cellular Cholesterol." Journal of Biochemical and Molecular Toxicology, vol. 35, no. 4, 2021, p. e22693, https://doi.org/10.1002/jbt.22693.